Adding bupivacaine to high-potassium cardioplegia improves function and reduces cellular damage of rat isolated hearts after prolonged, cold storage

Anesthesiology

Volumn 105, Issue 4, 2006, Pages 746-752

  Ross, James D ^a   Ripper, Richard ^a   Law, William R ^b   Massad, Malek ^a   Murphy, Patricia ^a   Edelman, Lucas ^b   Conlon, Beth ^a   Feinstein, Douglas L ^a   Palmer, June W ^a   DiGregorio, Guido ^c   Weinberg, Guy L ^b,d  

^a Department of Physiology and Biophysics ^*

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; LACTATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CELL DAMAGE; CONTROLLED STUDY; ENZYME RELEASE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART RATE; ISOLATED HEART; MALE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; CARDIOPLEGIC SOLUTIONS; COLD; FAT EMULSIONS, INTRAVENOUS; HEART; HEART ARREST, INDUCED; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIUM; ORGAN PRESERVATION SOLUTIONS; OXYGEN CONSUMPTION; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; TISSUE PRESERVATION;

EID: 33749186343     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200610000-00021     Document Type: Article

References (45)

1. Hunt SA: Current status of cardiac transplantation. JAMA 1998; 280:1692-8
2. Massad MG: Current trends in heart transplantation. Cardiology 2004; 101: 79-92
3. Chambers DJ: Polarization and myocardial protection. Curr Opin Cardiol 1999; 14:495-500
4. Strichartz GR, Sanchez V, Arthur GR, Chafetz R, Martin D: Fundamental properties of local anesthetics: II. Measured octanol:buffer partition coefficients and pKa values of clinically used drugs. Anesth Analg 1990; 71:158-70
5. Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ: Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. ANESTHESIOLOGY 1998; 88:1071-5
6. Weinberg G, Ripper R, Feinstein DL, Hoffman W: Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med 2003; 28:198-202
7. Weinberg G, Paisanthasan C, Feinstein D, Hoffman W: The effect of bupivacaine on myocardial tissue hypoxia and acidosis during ventricular fibrillation. Anesth Analg 2004; 98:790-5
8. Tyers GF: Metabolic arrest of the ischemic heart. Ann Thorac Surg 1975; 20:91-4
9. Doring V, Baumgarten HG, Pokar H, Gercken G: Metabolism and fine structure of the Mg++-procaine-arrested perfused heart. Basic Res Cardiol 1975; 70:186-97
10. Bretschneider HJ, Hubner G, Knoll D, Lohr B, Nordbeck H, Spieckermann PG: Myocardial resistance and tolerance to ischemia: Physiological and biochemical basis. J Cardiovasc Surg (Torino) 1975; 16:241-60
11. Sellevold OF, Berg EM, Levang OW: Procaine is effective for minimizing postischemic ventricular fibrillation in cardiac surgery. Anesth Analg 1995; 81:932-8
12. Snabaitis AK, Shattock MJ, Chambers DJ: Comparison of polarized and depolarized arrest in the isolated rat heart for long-term preservation. Circulation 1997; 96:3148-56
13. Chambers DJ: Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg 2003; 75:S661-6
14. Dobson GP, Jones MW: Adenosine and lidocaine: A new concept in nondepolarizing surgical myocardial arrest, protection, and preservation. J Thorac Cardiovasc Surg 2004; 127:794-805
15. Dobson GP: Organ arrest, protection and preservation: Natural hibernation to cardiac surgery. Comp Biochem Physiol B Biochem Mol Biol 2004; 139:469-85
16. Canyon SJ, Dobson GP: Protection against ventricular arrhythmias and cardiac death using adenosine and lidocaine during regional ischemia in the in vivo rat. Am J Physiol Heart Circ Physiol 2004; 287:H1286-95
17. Corvera JS, Kin H, Dobson GP, Kerendi F, Halkos ME, Katzmark S, Payne CS, Zhao ZQ, Guyton RA, Vinten-Johansen J: Polarized arrest with warm or cold adenosine/lidocaine blood cardioplegia is equivalent to hypothermic potassium blood cardioplegia. J Thorac Cardiovasc Surg 2005; 129:599-606
18. Dabadie P, Bendriss P, Erny P, Mazat JP: Uncoupling effects of local anesthetics on rat liver mitochondria. FEBS Lett 1987; 226:77-82
19. Sun X, Garlid KD: On the mechanism by which bupivacaine conducts protons across the membranes of mitochondria and liposomes. J Biol Chem 1992; 267:19147-54
20. Minners J, van den Bos EJ, Yellon DM, Schwalb H, Opie LH, Sack MN: Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: Support for a mitochondrial role in cardioprotection. Cardiovasc Res 2000; 47:68-73
21. Rodrigo GC, Lawrence CL, Standen NB: Dinitrophenol pretreatment of rat ventricular myocytes protects against damage by metabolic inhibition and reperfusion. J Mol Cell Cardiol 2002; 34:555-69
22. Sztark F, Malgat M, Dabadie P, Mazat JP: Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial bioenergetics. ANESTHESIOLOGY 1998; 88:1340-9
23. Sztark F, Ouhabi R, Dabadie P, Mazat JP: Effects of the local anesthetic bupivacaine on mitochondrial energy metabolism: Change from uncoupling to decoupling depending on the respiration state. Biochem Mol Biol Int 1997; 43:997-1003
24. Weinberg GL, Palmer JW, VadeBoncouer TR, Zuechner MB, Edelman G, Hoppel CL: Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria. ANESTHESIOLOGY 2000; 92:523-8
25. Parang P, Singh B, Arora R: Metabolic modulators for chronic cardiac ischemia. J Cardiovasc Pharmacol Ther 2005; 10:217-23
26. Mio Y, Fukuda N, Kusakari Y, Amaki Y, Tanifuji Y, Kurihara S: Comparative effects of bupivacaine and ropivacaine on intracellular calcium transients and tension in ferret ventricular muscle. ANESTHESIOLOGY 2004; 101:888-94
27. De Iuliis A, Zanatta L, Vincenti E, Galzigna L: Differences of ropivacaine and bupivacaine relevant to antiinflammatory activity, platelet aggregation and antioxidant activity in vitro. Farmaco 2001; 56:153-7
28. Leduc C, Gentili ME, Estebe JP, Le Corre P, Moulinoux JP, Ecoffey C: The effect of local anesthetics and amitriptyline on peroxidation in vivo in an inflammatory rat model: Preliminary reports. Anesth Analg 2002; 95:992-6
29. Lenfant F, Lahet JJ, Volot F, Schafer I, Freysz M, Rochette L: Effects of bupivacaine on human erythrocytes submitted to stress and evidence for an interaction between bupivacaine and flumazenil. Br J Clin Pharmacol 1999;48:826-8
30. Niiyama S, Tanaka E, Yamamoto S, Yasumoto S, Kano T, Higashi H: Bupivacaine, but not tetracaine, protects against the in vitro ischemic insult of rat hippocampal CA1 neurons. Neurosci Res 2002; 42:231-41
31. Yamada A, Tanaka E, Niiyama S, Yamamoto S, Hamada M, Higashi H: Protective actions of various local anesthetics against the membrane dysfunction produced by in vitro ischemia in rat hippocampal CA1 neurons. Neurosci Res 2004; 50:291-8
32. Garcia-Dorado D: Myocardial reperfusion injury: A new view. Cardiovasc Res 2004; 61:363-4
33. Butterworth J, James RL, Grimes J: Structure-affinity relationships and stereospecificity of several homologous series of local anesthetics for the beta2-adrenergic receptor. Anesth Analg 1997; 85:336-42
34. Nietgen GW, Chan CK, Durieux ME: Inhibition of lysophosphatidate signaling by lidocaine and bupivacaine. ANESTHESIOLOGY 1997; 86:1112-9
35. Bozkurt P, Suzer O, Ekici E, Demirci O, Kaya G, Hacibekiroglu M: Effects of bupivacaine used with sevoflurane on the rhythm and contractility in the isolated rat heart. Eur J Anaesthesiol 2003; 20:199-204
36. Chang DH, Ladd LA, Copeland S, Iglesias MA, Plummer JL, Mather LE: Direct cardiac effects of intracoronary bupivacaine, levobupivacaine and ropivacaine in the sheep. Br J Pharmacol 2001; 132:649-58
37. Clarkson CW, Hondeghem LM: Mechanism for bupivacaine depression of cardiac conduction: Fast block of sodium channels during the action potential with slow recovery from block during diastole. ANESTHESIOLOGY 1985; 62:396-405
38. Simon L, Kariya N, Edouard A, Benhamou D, Mazoit JX: Effect of bupivacaine on the isolated rabbit heart: Developmental aspect on ventricular conduction and contractility. ANESTHESIOLOGY 2004; 101:937-44
39. Timour Q, Freysz M, Lang J, Beal JL, Lakhal M, Bertrix L, Faucon G: Electrophysiological study in the dog of the risk of cardiac toxicity of bupivacaine. Arch Int Pharmacodyn Ther 1987; 287:65-77
40. Heavner JE: Cardiac toxicity of local anesthetics in the intact isolated heart model: A review. Reg Anesth Pain Med 2002; 27:545-55
41. Groban L, Deal DD, Vernon JC, James RL, Butterworth J: Cardiac resuscitation after incremental overdosage with lidocaine, bupivacaine, levobupivacaine, and ropivacaine in anesthetized dogs. Anesth Analg 2001; 92:37-43
42. Lynch C, 3rd: Depression of myocardial contractility in vitro by bupivacaine, etidocaine, and lidocaine. Anesth Analg 1986; 65:551-9
43. Freysz M, Timour Q, Mazze RI, Bertrix L, Cohen S, Samii K, Faucon G: Potentiation by mild hypothermia of ventricular conduction disturbances and reentrant arrhythmias induced by bupivacaine in dogs. ANESTHESIOLOGY 1989; 70:799-804
44. Freysz M, Timour Q, Bertrix L, Loufoua-Moundanga J, Omar S, Faucon G: Enhancement by ischemia of the risk of cardiac disorders, especially fibrillation, in regional anesthesia with bupivacaine. Acta Anaesthesiol Scand 1993; 37:350-6
45. Freysz M, Timour Q, Bertrix L, Loufoua J, Aupetit JF, Faucon G: Bupivacaine hastens the ischemia-induced decrease of the electrical ventricular fibrillation threshold. Anesth Analg 1995; 80:657-63